Its lead product candidate is ADI-001, an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, which is in Phase I clinical trial for the treatment of autoimmune diseases and ...
Christiane Eberhardt. Christiane Sigrid Eberhardt is a physician-scientist with a background in vaccine-immunology and is currently working as clinical vaccinologist at the Center ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback